Vivitrol is not a controlled substance. It has no DEA schedule classification and is not listed under the Controlled Substances Act. This makes it fundamentally different from the other two FDA-approved medications for opioid use disorder, both of which carry controlled substance restrictions.
Why Vivitrol Is Not Scheduled
The reason comes down to how the drug works in your brain. Vivitrol’s active ingredient, naltrexone, is an opioid antagonist. It binds to the same receptors that opioids target, but instead of activating them, it blocks them. Think of it like a key that fits into a lock but won’t turn. It just sits there, preventing anything else from getting in.
Because naltrexone blocks opioid receptors rather than stimulating them, it produces no euphoria, no sedation, and no “high” of any kind. There is no potential for physical dependence on the medication itself, and it has no street value. These are the characteristics the DEA evaluates when deciding whether a substance needs scheduling, and naltrexone checks none of the boxes.
How It Compares to Other Addiction Medications
The FDA has approved three medications for opioid use disorder: naltrexone (sold as Vivitrol), buprenorphine (the active ingredient in Suboxone), and methadone. Despite sharing the same treatment goal, these three drugs sit in very different regulatory categories.
Methadone is a Schedule II controlled substance, the same category as oxycodone and fentanyl. It activates opioid receptors directly, carries real potential for misuse, and can only be dispensed for addiction treatment through federally certified opioid treatment programs. Patients typically must visit a clinic daily to receive their dose, at least initially.
Buprenorphine is a Schedule III controlled substance. It partially activates opioid receptors, producing milder effects than full agonists like methadone but still carrying some potential for misuse and diversion. Providers can now prescribe buprenorphine without the special X-waiver that was previously required, though it still comes with controlled substance documentation and monitoring requirements.
Vivitrol, by contrast, requires no special waiver, no controlled substance prescription pad, and no daily clinic visits for dispensing. Any licensed healthcare provider can prescribe it. The primary regulatory requirement is simply that it must be prepared and administered by a healthcare provider rather than self-injected at home.
What the Injection Involves
Vivitrol is given as a deep intramuscular injection into the gluteal muscle once every four weeks. A healthcare provider administers the 380 mg dose in a clinical setting, alternating sides each month. You cannot take Vivitrol at home or inject it yourself. It comes with a specific diluent and needle kit, and the provider must prepare the suspension fresh before each injection.
This administration method is part of what makes Vivitrol appealing for some patients. Because you receive it once a month in a provider’s office, there’s no daily pill to remember, no prescription bottle at home that could be lost or diverted, and no decision to make each morning about whether to take your medication. The drug slowly releases from the injection site over the following weeks.
What “Not Controlled” Means for You
If you’re considering Vivitrol or already taking it, its non-controlled status has several practical implications. Employment drug screenings do not test for naltrexone, and having a Vivitrol prescription does not show up in prescription drug monitoring programs the way controlled substances do. You won’t face the same pharmacy restrictions, refill limits, or ID requirements associated with scheduled medications.
For people in recovery who are navigating jobs, housing applications, or legal situations, this distinction matters. Being on Vivitrol does not carry the same regulatory footprint as being prescribed methadone or buprenorphine, even though all three are legitimate, FDA-approved treatments for the same condition.
One important caution: while Vivitrol itself has no abuse potential, it does not make you immune to opioids. If you stop receiving injections and your opioid receptors are no longer blocked, your tolerance will be significantly lower than it was before treatment. Using opioids at that point, especially at previously tolerated doses, creates a serious overdose risk. The medication is a tool that works while it’s active in your system, not a permanent reset.